FISH VACCINE MARKET ANALYSIS

Fish Vaccine Market, By Vaccine Type (Killed Vaccine, Inactivated Vaccine, Attenuated Vaccine, Toxoid Vaccine, Subunit Vaccine, Conjugate Vaccine, Recombinant Vector Vaccines), By Indication (Furunculosis, Vibriosis, Yersiniosis, Enteric septicaemia, Others), By Route of Administration (Injection, Immersion, Spray, Oral), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

On January 5, 2024, according to the World Organization for Animal Health, a project in the Philippines is underway to create a vaccine against the Tilapia Lake Virus (TiLV), a newly identified viral pathogen
In November 2022, Indian Immunologicals (IIL), a veterinary and human biologicals company, partnered with the Central Institute of Freshwater Aquaculture (CIFA),a research institute, to develop a vaccine against hemorrhagic septicemia in freshwater fish. The partnership aims to combat common bacterial diseases in these fish, including Columnaris Disease and Edwardsiellosis. CIFA, under ICAR, will provide the technology for the vaccines.